# BEPOTASTINE BESILATE
> **ANDA206080** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2017-06-07
## Drug
- **FDA Application Number:** ANDA206080
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEPOTASTINE BESILATE
- **Generic name:** Bepotastine Besilate
- **Active ingredients:** BEPOTASTINE BESILATE
- **Dosage form:** SOLUTION
- **Route:** OPHTHALMIC
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2017-06-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206080)
---
*MORVS · CC0 1.0*